These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7400830)

  • 1. Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans.
    McDougall IR; Bayer MF
    J Nucl Med; 1980 Aug; 21(8):741-4. PubMed ID: 7400830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
    Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
    Degrossi OJ; Rozados IB; Damilano S; Degrossi EB; de Ganino L; Pinkas M; García del Río H; Artagaveytía D
    Medicina (B Aires); 1991; 51(4):291-5. PubMed ID: 1821916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of repeat stimulated thyroglobulin testing in patients with differentiated thyroid carcinoma considered to be free of disease in the first year after ablation.
    Rosario PW; Furtado MS; Mineiro Filho AF; Lacerda RX; Calsolari MR
    Thyroid; 2012 May; 22(5):482-6. PubMed ID: 22175271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue?
    Van Wyngaarden K; McDougall IR
    Thyroid; 1997 Jun; 7(3):343-6. PubMed ID: 9226201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroglobulin as a tumor marker and thallium scintigraphy for the course control of differentiated thyroid cancer].
    Müller-Brand J; Fridrich R; Spicher E; Staub JJ
    Schweiz Med Wochenschr; 1983 Mar; 113(9):325-7. PubMed ID: 6844904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
    Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
    Pacini F; Molinaro E; Lippi F; Castagna MG; Agate L; Ceccarelli C; Taddei D; Elisei R; Capezzone M; Pinchera A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroglobulin in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E
    Scand J Clin Lab Invest Suppl; 1991; 206():79-84. PubMed ID: 1947763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer.
    Ramanna L; Waxman AD; Brachman MB; Sensel N; Tanasescu DE; Berman DS; Catz B; Braunstein GD
    Cancer; 1985 Apr; 55(7):1525-9. PubMed ID: 3978546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
    Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
    Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compared to whole body scanning thyroglobulin assay is reliable in the follow-up of thyroidectomized patients with thyroid carcinoma].
    van den Bergh JP; Pieters GF; Beex LV; Ross HA; Corstens FH; Smals AG
    Ned Tijdschr Geneeskd; 1993 Jul; 137(27):1344-8. PubMed ID: 8350939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyroglobulin in differentiated thyroid carcinoma.
    Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
    Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.